Literature DB >> 10772314

Intracanalicular schwannoma of the facial nerve: a manifestation of neurofibromatosis type 2.

A A Saada1, C J Limb, D M Long, J K Niparko.   

Abstract

Primary facial nerve tumors, which are relatively uncommon, can present a diagnostic dilemma based on their location and variable pattern of symptoms. Of primary cranial nerve tumors, schwannomas of the facial nerve rank third in frequency after those of the eighth and fifth cranial nerves. We report an illustrative case of an intracanalicular schwannoma associated with several central nervous system tumors, consistent with neurofibromatosis type 2. Initially assumed to be an eighth cranial nerve tumor, the schwannoma was found intraoperatively to arise from the facial nerve. Early diagnosis and treatment enabled excision of the tumor without sacrifice of the facial nerve. Facial nerve schwannomas can resemble acoustic schwannomas in their clinical presentation. Only a heightened level of clinical vigilance will point to the correct diagnosis and result in an optimal therapeutic outcome for patients with these rare tumors.

Entities:  

Mesh:

Year:  2000        PMID: 10772314     DOI: 10.1001/archotol.126.4.547

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  4 in total

1.  Surgical management of internal auditory canal and cerebellopontine angle facial nerve schwannoma.

Authors:  Sarah Mowry; Marlan Hansen; Bruce Gantz
Journal:  Otol Neurotol       Date:  2012-08       Impact factor: 2.311

2.  Facial Nerve Neuroma : A Case Report.

Authors:  A K Das; R C Kashyap; A Dutta
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Facial nerve neuroma: clinical, diagnostic, and surgical features.

Authors:  Tayfun Kirazli; Kazim Oner; Cem Bilgen; Izzet Ovül; Raşit Midilli
Journal:  Skull Base       Date:  2004-05

Review 4.  Cerebellopontine angle schwannomas arising from the intermediate nerve: a scoping review.

Authors:  Felipe Constanzo; Bernardo Corrêa de Almeida Teixeira; Patricia Sens; Dante Escuissato; Ricardo Ramina
Journal:  Neurosurg Rev       Date:  2019-09-14       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.